Harrow Health, Inc. 11.875% Senior Notes due 2027
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-22.31-14.88-16.50-41.3037.043.72K-190.68-36.73-48.89-34.47-27.893.72K
Price/Sales ratio
136.0024.3615.7918.4913.0912.2313.099.127.776.467.9212.23
Price/Book Value ratio
27.70-170.9148.97189.3221.8922.5823.5458.6024.9511.8916.0022.58
Price/Cash Flow ratio
-31.99-21.24-28.08-56.24788.64658.93-581.93130.15403.94219.148.21K788.64
Price/Free Cash Flow ratio
-31.22-18.42-17.16-50.12-357.38-705.73-305.69-61.03-113.50353.57-59.08-357.38
Price/Earnings Growth ratio
-0.85-0.301.710.68-0.17-37.630.09-0.082.04-0.730.21-0.17
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A0.01%N/AN/A11.28%N/A
Profitability Indicator Ratios
Gross Profit Margin
34.15%46.41%50.70%49.55%60.06%67.26%70.40%74.86%71.34%69.55%71.15%60.06%
Operating Profit Margin
-611.26%-152.55%-78.12%-45.42%-12.61%-0.53%0.18%2.43%2.05%0.33%-5.28%-12.61%
Pretax Profit Margin
-609.51%-163.63%-96.26%-48.25%35.35%-0.22%-8.33%-24.80%-15.92%-18.21%-20.70%-0.22%
Net Profit Margin
-609.51%-163.63%-95.71%-44.76%35.35%0.32%-6.86%-24.84%-15.89%-18.74%-21.78%0.32%
Effective Tax Rate
N/A0.08%0.57%7.23%11.49%-6.83%16.07%-0.17%0.18%-2.95%-5.19%-6.83%
Return on Assets
-98.78%-112.51%-70.05%-50.11%29.57%0.28%-5.84%-18.31%-8.95%-7.81%-10.95%0.28%
Return On Equity
-124.14%1147.94%-296.75%-458.31%59.08%0.60%-12.34%-159.55%-51.04%-34.49%-50.73%0.60%
Return on Capital Employed
-116.87%-169.25%-89.83%-67.03%-13.89%-0.58%0.19%1.98%1.31%0.16%-3.21%-13.89%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.59N/A
Quick Ratio
5.560.831.301.132.602.663.345.805.992.592.412.66
Cash ratio
5.260.490.910.730.570.400.394.335.161.501.320.57
Days of Sales Outstanding
17.8131.5553.4622.1317.3214.3319.8822.7526.31102.29123.6417.32
Days of Inventory outstanding
124.5698.9968.3560.7840.5171.9399.9884.5094.05100.0677.3740.51
Operating Cycle
142.37130.55121.8182.9257.8486.26119.86107.26120.37202.35201.0157.84
Days of Payables Outstanding
262.81238.86131.35105109.71161.4591.98103.6892.60197.26165.64109.71
Cash Conversion Cycle
-120.44-108.31-9.54-22.07-51.86-75.1927.883.5727.775.0935.37-51.86
Debt Ratios
Debt Ratio
N/A0.600.440.580.290.230.280.720.660.580.600.29
Debt Equity Ratio
N/A-6.161.885.370.580.500.596.343.772.583.160.58
Long-term Debt to Capitalization
N/A1.190.550.840.320.300.310.860.790.720.750.32
Total Debt to Capitalization
N/A1.190.650.840.360.330.370.860.790.720.750.36
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-0.74N/A
Cash Flow to Debt Ratio
N/A-1.30-0.92-0.620.040.06-0.060.070.010.020.000.06
Company Equity Multiplier
1.25-10.204.239.141.992.132.118.715.704.415.231.99
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-4.25-1.14-0.56-0.320.010.01-0.020.070.010.020.000.01
Free Cash Flow / Operating Cash Flow Ratio
1.021.151.631.12-2.20-0.931.90-2.13-3.550.61-181.35-0.93
Cash Flow Coverage Ratio
N/A-1.30-0.92-0.620.040.06-0.060.070.010.020.000.06
Short Term Coverage Ratio
N/A-56.27-2.68-166.090.270.53-0.28N/AN/AN/AN/A0.53
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A-0.70%N/AN/AN/AN/A